2
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Myeloid
1
Classical hematology
1
Conditions
Prostatic Neoplasms
21
Carcinoma, Non-Small-Cell Lung
21
Breast Neoplasms
20
Neoplasms
19
Stomach Neoplasms
15
Colorectal Neoplasms
15
Lung Neoplasms
13
Endometrial Neoplasms
13
Pancreatic Neoplasms
11
Leukemia, Myeloid, Acute
10
Colonic Neoplasms
9
Carcinoma, Hepatocellular
9
Melanoma
7
Oropharyngeal Neoplasms
6
Neoplasm Metastasis
6
Multiple Myeloma
6
Lymphoma, Large B-Cell, Diffuse
6
Esophageal Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
5
Sarcoma
5
Rectal Neoplasms
5
Mouth Neoplasms
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Head and Neck Neoplasms
5
Uterine Cervical Neoplasms
4
Recurrence
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoma, Mantle-Cell
4
Leukemia, Myelomonocytic, Acute
4
Leukemia, Monocytic, Acute
4
Interventions
eltrombopag
14
romiplostim
7
avatrombopag
7
Platelet Transfusion
6
Cytarabine
6
Radiotherapy
4
Filgrastim
4
Etoposide
4
Carboplatin
4
oprelvekin
3
Tranexamic Acid
3
Peripheral Blood Stem Cell Transplantation
3
Daunorubicin
3
Cyclophosphamide
3
Busulfan
3
hetrombopag
2
fludarabine phosphate
2
Tretinoin
2
Thrombopoietin
2
Lenalidomide
2
Interleukin-11
2
Ifosfamide
2
Granulocyte Colony-Stimulating Factor
2
Doxorubicin
2
Cyclosporine
2
Amplified Fragment Length Polymorphism Analysis
2
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
2
sodium thiosulfate
1
siltuximab
1
sargramostim
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Thrombocytopenia
×
Observation
×
Clear all
NCT07108023
2025-08-06
EHPVO-HEM
Assiut University
Not yet recruiting
115 enrolled